Results 111 to 120 of about 8,269 (200)

A case of lysozyme-induced nephropathy with improved renal function following treatment for chronic myelomonocytic leukemia. [PDF]

open access: yesCEN Case Rep
Nukui N   +6 more
europepmc   +1 more source

Timdarpacept (IMM01) combined with azacitidine (AZA) as first-line therapy in adults with higher risk chronic myelomonocytic leukemia (CMML): results from a prospective, multicenter, phase II study. [PDF]

open access: yesExp Hematol Oncol
Ma L   +18 more
europepmc   +1 more source

Systemic Metabolic Changes in Plasma of Patients with Myelodysplastic Neoplasms and Chronic Myelomonocytic Leukemia. [PDF]

open access: yesMetabolites
Balaian E   +14 more
europepmc   +1 more source

A phase 1b/2 study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML. [PDF]

open access: yesBlood Adv
Brunner AM   +19 more
europepmc   +1 more source

<i>TCL1A</i> polymorphism predicts AML progression in myeloid neoplasms. [PDF]

open access: yesBlood Neoplasia
Molina A   +6 more
europepmc   +1 more source

KIT mutation and AHN-associated oncogenic profiles in systemic mastocytosis with an associated hematological neoplasm. [PDF]

open access: yesBlood Adv
Navarro-Navarro P   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy